IndraLab
Statements
sparser
"In general, while methylation of p53 at K370, K373 and K382 represses p53 transcriptional activities, methylation at K372 enhances p53 activities. xref – xref Since KDM3A knockdown activated the expression of p53-dependent genes, we reasoned that increasing p53 methylation enhanced its transcriptional activities."
sparser
"The lysine K373 of p53 interacts directly with the side-chain of SMYD2Y344 through van der Waals interactions, whereas its ε-amine of p53K373 forms hydrogen bonds OH groups of Y370 and Y374. xref Thus, G9A-mediated dimethylation of p53, p53K373me2, could hypothetically increase interactions with SMYD2 aromatic cage, as seen with the cation-π interactions-mediated increased affinity between ING4 PHD and H3K4 me3 , xref and lead to methylation of p53 at K370."
sparser
"In this study, we disclose LLY-507, a small molecule inhibitor of SMYD2 with the following biochemical, biophysical, and cellular properties: 1) has low nanomolar IC 50 in SMYD2 biochemical assays; 2) has 100-fold selectivity for SMYD2 over 24 other protein or DNA methyltransferases including related family members SMYD3, SUVH420H1, and SUV420H2; 3) inactive (>20 μ m ) against 454 kinases, 35 G protein-coupled receptors, 14 nuclear hormone receptors, and three cytochrome P450 enzymes; 4) binds to substrate channel of SMYD2 based upon a high (1.6-Å) resolution crystal structure; 5) has submicromolar cell-based potency as demonstrated by its ability to inhibit the mono-methylation of Lys 370 of p53 in several different cell systems; and 6) has antiproliferative activity in tumor types in which SMYD2 is amplified and/or overexpressed."